Baseline demographic and disease characteristics of patients with UCD and iMCD
| . | UCD (43) . | iMCD (31) . | P value . |
|---|---|---|---|
| Age (y) | |||
| ≤40 | 20 (46.51) | 11 (35.50) | .406 |
| >40 | 23 (53.49) | 20 (64.50) | |
| Sex | |||
| Male | 19 (44.19) | 11 (35.50) | .452 |
| Female | 24 (55.81) | 20 (64.50) | |
| Pathological lymph node type | |||
| HV | 32 (74.42) | 16 (51.62) | .176 |
| PC | 11 (25.58) | 15 (48.38) | |
| Medical history of autoimmune connective tissue disease | 4 (9.3) | 12 (38.71) | .019 |
| Asthma | 1 (2.33) | 4 (12.90) | |
| Idiopathic thrombocytopenic purpura | 1 (2.33) | 1 (3.23) | |
| Rheumatoid arthritis | 0 (0) | 1 (3.23) | |
| Pemphigus vulgaris | 1 (2.33) | 0 (0) | |
| Myasthenia gravis | 1 (2.33) | 0 (0) | |
| Systemic lupus erythematosus | 0 (0) | 1 (3.23) | |
| Antiphospholipid syndrome | 0 (0) | 1 (3.23) | |
| Thrombotic thrombocytopenic purpura | 0 (0) | 2 (6.46) | |
| Autoimmune disorder | 0 (0) | 2 (6.46) | |
| Symptomatic | 18 (41.86) | 25 (80.65) | .007 |
| Fever | 3 (6.98) | 4 (12.90) | .357 |
| Pleural effusion and/or ascites | 0 (0) | 4 (12.90) | .049 |
| Hepatomegaly and/or splenomegaly | 1 (2.33) | 6 (19.35) | .044 |
| B-symptoms | 8 (18.60) | 13 (41.93) | .048 |
| Organ failure (liver or kidney) | 0 (0) | 2 (6.46) | .172 |
| . | UCD (43) . | iMCD (31) . | P value . |
|---|---|---|---|
| Age (y) | |||
| ≤40 | 20 (46.51) | 11 (35.50) | .406 |
| >40 | 23 (53.49) | 20 (64.50) | |
| Sex | |||
| Male | 19 (44.19) | 11 (35.50) | .452 |
| Female | 24 (55.81) | 20 (64.50) | |
| Pathological lymph node type | |||
| HV | 32 (74.42) | 16 (51.62) | .176 |
| PC | 11 (25.58) | 15 (48.38) | |
| Medical history of autoimmune connective tissue disease | 4 (9.3) | 12 (38.71) | .019 |
| Asthma | 1 (2.33) | 4 (12.90) | |
| Idiopathic thrombocytopenic purpura | 1 (2.33) | 1 (3.23) | |
| Rheumatoid arthritis | 0 (0) | 1 (3.23) | |
| Pemphigus vulgaris | 1 (2.33) | 0 (0) | |
| Myasthenia gravis | 1 (2.33) | 0 (0) | |
| Systemic lupus erythematosus | 0 (0) | 1 (3.23) | |
| Antiphospholipid syndrome | 0 (0) | 1 (3.23) | |
| Thrombotic thrombocytopenic purpura | 0 (0) | 2 (6.46) | |
| Autoimmune disorder | 0 (0) | 2 (6.46) | |
| Symptomatic | 18 (41.86) | 25 (80.65) | .007 |
| Fever | 3 (6.98) | 4 (12.90) | .357 |
| Pleural effusion and/or ascites | 0 (0) | 4 (12.90) | .049 |
| Hepatomegaly and/or splenomegaly | 1 (2.33) | 6 (19.35) | .044 |
| B-symptoms | 8 (18.60) | 13 (41.93) | .048 |
| Organ failure (liver or kidney) | 0 (0) | 2 (6.46) | .172 |
Data represent n (%) of patients. Significant P values are in bold.